Annette A. van Zweeden

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Johanna W. Wilmink · 3 shared papers, 2015–2025 · strength 0.71
   • Paper Reply to Comments on "Reintroduction of palliative intent FOLFIRINOX chemotherapy in a real world pancreatic cancer coh… DOI 10.1016/j.pan.2025.07.012↗
   • Paper Reintroduction of palliative intent FOLFIRINOX chemotherapy in a real world pancreatic cancer cohort. DOI 10.1016/j.pan.2025.03.011↗
   • Paper Phase I Clinical Trial to Determine the Feasibility and Maximum Tolerated Dose of Panitumumab to Standard Gemcitabine-B… DOI 10.1158/1078-0432.ccr-14-3364↗
2. Lydia G. van der Geest · 2 shared papers, 2025 · strength 0.66
   • Paper Reply to Comments on "Reintroduction of palliative intent FOLFIRINOX chemotherapy in a real world pancreatic cancer coh… DOI 10.1016/j.pan.2025.07.012↗
   • Paper Reintroduction of palliative intent FOLFIRINOX chemotherapy in a real world pancreatic cancer cohort. DOI 10.1016/j.pan.2025.03.011↗
3. Henk M.W. Verheul · 2 shared papers, 2015–2025 · strength 0.28
   • Paper Reintroduction of palliative intent FOLFIRINOX chemotherapy in a real world pancreatic cancer cohort. DOI 10.1016/j.pan.2025.03.011↗
   • Paper Phase I Clinical Trial to Determine the Feasibility and Maximum Tolerated Dose of Panitumumab to Standard Gemcitabine-B… DOI 10.1158/1078-0432.ccr-14-3364↗
4. Jeanin Elise van Hooft · 1 shared paper, 2025 · strength 0.24
   • Paper Reintroduction of palliative intent FOLFIRINOX chemotherapy in a real world pancreatic cancer cohort. DOI 10.1016/j.pan.2025.03.011↗
5. Esther N. Pijnappel · 1 shared paper, 2025 · strength 0.24
   • Paper Reintroduction of palliative intent FOLFIRINOX chemotherapy in a real world pancreatic cancer cohort. DOI 10.1016/j.pan.2025.03.011↗
6. Hanneke W.M. van Laarhoven · 1 shared paper, 2025 · strength 0.24
   • Paper Reintroduction of palliative intent FOLFIRINOX chemotherapy in a real world pancreatic cancer cohort. DOI 10.1016/j.pan.2025.03.011↗
7. Judith de Vos‐Geelen · 1 shared paper, 2025 · strength 0.24
   • Paper Reintroduction of palliative intent FOLFIRINOX chemotherapy in a real world pancreatic cancer cohort. DOI 10.1016/j.pan.2025.03.011↗
8. Martijn W.J. Stommel · 1 shared paper, 2025 · strength 0.24
   • Paper Reintroduction of palliative intent FOLFIRINOX chemotherapy in a real world pancreatic cancer cohort. DOI 10.1016/j.pan.2025.03.011↗
9. Martijn Ruben Meijerink · 1 shared paper, 2015 · strength 0.05
   • Paper Phase I Clinical Trial to Determine the Feasibility and Maximum Tolerated Dose of Panitumumab to Standard Gemcitabine-B… DOI 10.1158/1078-0432.ccr-14-3364↗
10. Geertjan van Tienhoven · 1 shared paper, 2015 · strength 0.05
    • Paper Phase I Clinical Trial to Determine the Feasibility and Maximum Tolerated Dose of Panitumumab to Standard Gemcitabine-B… DOI 10.1158/1078-0432.ccr-14-3364↗
11. Anna M E Bruynzeel · 1 shared paper, 2015 · strength 0.05
    • Paper Phase I Clinical Trial to Determine the Feasibility and Maximum Tolerated Dose of Panitumumab to Standard Gemcitabine-B… DOI 10.1158/1078-0432.ccr-14-3364↗
12. Geert Kazemier M · 1 shared paper, 2015 · strength 0.05
    • Paper Phase I Clinical Trial to Determine the Feasibility and Maximum Tolerated Dose of Panitumumab to Standard Gemcitabine-B… DOI 10.1158/1078-0432.ccr-14-3364↗
13. Elisa Giovannetti · 1 shared paper, 2015 · strength 0.05
    • Paper Phase I Clinical Trial to Determine the Feasibility and Maximum Tolerated Dose of Panitumumab to Standard Gemcitabine-B… DOI 10.1158/1078-0432.ccr-14-3364↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.